These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16179885)

  • 1. Diabetes mellitus and percutaneous coronary revascularization.
    Corros C; Jiménez-Quevedo P; Sabaté M
    Minerva Cardioangiol; 2005 Oct; 53(5):431-43. PubMed ID: 16179885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.
    Jiménez-Quevedo P; Sabaté M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):635-46. PubMed ID: 16076274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left main coronary artery stenosis].
    Sheiban I; Biondi-Zoccai GG; Moretti C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):684-9. PubMed ID: 18942556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.
    Ben-Gal Y; Mohr R; Uretzky G; Medalion B; Hendler A; Hansson N; Herz I; Moshkovitz Y
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):861-6. PubMed ID: 17000298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated management of patients with diabetes mellitus and ischemic heart disease: PCI, CABG, and medical therapy.
    Barsness GW; Holmes DR; Gersh BJ
    Curr Probl Cardiol; 2005 Nov; 30(11):583-617. PubMed ID: 16230183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex coronary interventions: unprotected left main and bifurcation lesions.
    Barlis P; Tanigawa J; Kaplan S; di Mario C
    J Interv Cardiol; 2006 Dec; 19(6):510-24. PubMed ID: 17107366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current drug-eluting stents in complex patients and lesions.
    Elezi S; Dibra A; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary interventions with drug eluting stents for diabetic patients.
    Seabra-Gomes R
    Heart; 2006 Mar; 92(3):410-9. PubMed ID: 16501210
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.
    Ben-Gal Y; Moshkovitz Y; Nesher N; Uretzky G; Braunstein R; Hendler A; Zivi E; Herz I; Mohr R
    Ann Thorac Surg; 2006 Nov; 82(5):1692-7. PubMed ID: 17062230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic options in patients with diabetes mellitus type 2 and coronary artery disease: intensified secondary prevention versus percutaneous or surgical revascularization].
    Sixt S; Schuler G; Niebauer J
    Dtsch Med Wochenschr; 2004 Jun; 129(24):1385-9. PubMed ID: 15188092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent era: will we improve 5-year outcomes?
    Cutlip DE
    Coron Artery Dis; 2006 Dec; 17(8):681-4. PubMed ID: 17119376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.